US 9822162
Anti-human papillomavirus 16 E6 T cell receptors
granted A61KA61K38/00A61K40/11
Quick answer
US patent 9822162 (Anti-human papillomavirus 16 E6 T cell receptors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 39
- CPC classes
- A61K, A61K38/00, A61K40/11, A61K40/32, A61K40/4272